The accompanying notes
are an integral part of these consolidated financial statements.
The accompanying notes
are an integral part of these consolidated financial statements.
The accompanying notes
are an integral part of these consolidated financial statements.
The accompanying notes
are an integral part of these consolidated financial statements.
Notes to the Consolidated
Financial Statements
NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
Nature of the Business
REGO Payment Architectures, Inc. (“REGO”)
was incorporated in the state of Delaware on February 11, 2008.
REGO Payment Architectures, Inc. and its subsidiaries (collectively,
except where the context requires, the “Company”) is a provider of consumer software that delivers a mobile payment platform
solution—MazoolaSM - a family focused mobile banking solution. Headquartered in Blue Bell, Pennsylvania, the Company
maintains a portfolio of trade secrets and four US patent awards. REGO offers an all-digital financial payments platform to enable minors,
particularly under 13 years old, to purchase goods and services, complete chores and learn in a secure online environment guided by parental
permission, oversight, and control, while remaining COPPA and GDPR compliant.
Management believes that
building on its COPPA advantage that the future of REGO Payment Architectures, Inc. will be based on the foundational architecture of
the Platform that will allow its use across multiple financial markets where secure controlled payments are needed. The Company
intends to license in each alternative field of use the ability for its partners, distributors and/or value added resellers to private
label each of the alternative markets. These partners would deploy, customize and support each implementation under their own label,
but with acknowledgement of the Company’s proprietary intellectual assets as the base technology. Management believes this
approach will enable the Company to reduce expenses while broadening its reach.
Revenues generated from the platform will
come from multiple sources depending on the level of service and facilities requested by the parent. There will be levels of subscription
revenue paid monthly, service fees, transaction fees and in some cases revenue sharing and licensing with banking and distribution partners.
ZOOM Solutions, Inc. (“ZS”)
ZS (formerly Zoom Payment
Solutions, Inc.) was incorporated in the state of Delaware on February 16, 2018 as a subsidiary of REGO Payment Architectures, Inc. During
the year ended December 31, 2020, the minority common shareholders of ZS exchanged their shares in ZS for REGO 10% secured convertible
notes payable. REGO now owns 100% of the common stock of ZS. ZS is the holding company for various subsidiaries that will utilize
REGO’s payment platform to address emerging markets.
There were minimal operations at ZS during
the years 2020 and 2019.
ZOOM Payment Solutions, Inc. (“ZPS”)
ZPS (formerly Zoom Payment Solutions USA, Inc.)
was incorporated in the state of Nevada on December 6, 2017. ZPS is a wholly owned subsidiary of ZS with the core focus on providing
mobile payments solutions. ZPS has secured a sublicense from ZS for the REGO payment platform and access to the patents from REGO.
There were minimal operations at ZPS during
the years 2020 and 2019.
ZOOM Blockchain Solutions, Inc. (“ZBS”)
ZBS was incorporated in the state of Delaware
on April 20, 2018 as an 85% owned subsidiary of ZS. This company was focused on blockchain as a business solution for the retail and Consumer
Packaged Goods (“CPG”) industries.
There were minimal operations at ZBS during the years 2020 and 2019.
ZOOM Cloud Solutions, Inc. (“ZCS”)
ZCS (formerly Zoom Canada Solutions, Inc.) was
incorporated in the state of Delaware on April 20, 2018 as an 85% owned subsidiary of ZS. ZCS was focused on providing a highly secure
cloud storage as a service.
There were minimal operations at ZCS during the
years 2020 and 2019.
ZOOM Auto Solutions, Inc. (“ZAS”)
ZAS (formerly Zoom Mining Solutions) was incorporated
in the State of Delaware on February 19, 2018 as a wholly owned subsidiary of ZCS. It is now a wholly owned subsidiary of ZBS.
There were minimal operations at ZAS during
the years 2020 and 2019.
The Company’s principal office is located
in Blue Bell, Pennsylvania.
Basis of Presentation
The accompanying consolidated financial statements
of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“US
GAAP”). All significant intercompany transactions and balances have been eliminated in consolidation.
The Company’s activities are subject
to significant risks and uncertainties, including failing to secure additional financing to operationalize the Company’s current
technology before another company develops similar technology to compete with the Company.
Use of Estimates
The preparation of financial statements in
conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
these estimates.
Fair Value of Financial Instruments
The Company’s financial instruments
consist of accounts payable and accrued expenses and notes payable. The carrying value of accounts payable and accrued expenses approximate
their fair value because of their short maturities. The Company believes the carrying amount of its notes payable approximate fair
value based on rates and other terms currently available to the Company for similar debt instruments.
The Company follows FASB ASC 820, Fair
Value Measurements and Disclosures, and applies it to all assets and liabilities that are being measured and reported on a fair value
basis. The statement requires that assets and liabilities carried at fair value will be classified and disclosed in one of
the following three categories:
Level 1: Quoted market price in active markets
for identical assets or liabilities
Level 2: Observable market based inputs or
unobservable inputs that are corroborated by market data
Level 3: Unobservable inputs that are not
corroborated by market data
The level in the fair value hierarchy within
which a fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.
Concentration of Credit Risk Involving
Cash
The Company may have deposits with a financial
institution which at times exceed Federal Deposit Insurance Corporation (“FDIC”) coverage. The Company has not
experienced any losses from maintaining cash accounts in excess of federally insured limits.
Cash and Cash Equivalents
For purposes of reporting cash flows, the
Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial
paper with original maturities of 90 days or less to be cash or cash equivalents.
Accounts Receivable
Accounts receivable are stated
at the amount management expects to collect from outstanding balances. Management provides for probable uncollectible amounts through
a charge to earnings and a credit to a valuation allowance based on its assessment of the current status of individual accounts. Balances
that are still outstanding after management has used reasonable collection efforts are written off through a charge to the valuation allowance
and a credit to trade accounts receivable. Management believes that all of the accounts receivable are collectible and has not provided
for uncollectible amounts nor written off any amounts.
Property and Equipment
Property, equipment and leasehold improvements
are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets.
Maintenance and repairs of property are charged to operations, and major improvements are capitalized. Upon retirement, sale, or other
disposition of property and equipment, the costs and accumulated depreciation are eliminated from the accounts, and any resulting gain
or loss is included in operations. The cost of leasehold improvements is amortized over the lesser of the length of the related
leases or the estimated useful lives of the assets.
Patents and Trademarks
The Company has four issued patents with
the United States Patent and Trademark Office (“USPTO”), entitled “System and Method for Verifying the Age of an
Internet User,” “System and Method for Virtual Piggy Bank Wish-List,” “Parent Match” and “System
and Method for Virtual Piggy Bank.” The Company has filed for one provisional U.S. patent application, as well as twelve
non-provisional U.S. patent applications, two of which are pending, four of which have been allowed, and seven of which
have been abandoned. Additionally, the Company has been granted two patents, entitled “Virtual Piggy Bank”
and “Parent Match,” in each of Germany, Canada, and Australia. The Company also has patents pending in the
Republic of Korea under the Patent Cooperation Treaty (“PCT”). Costs associated with the registration and
legal defense of the patents have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents.
Long-Lived Assets
The Company evaluates the recoverability of
its long-lived assets in accordance with FASB ASC 360 Property, Plant, and Equipment. The Company reviews long-lived
assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
Recoverability of long-lived assets are measured by a comparison of the carrying amount of an asset to future cash flows expected to be
generated by the asset, undiscounted and without interest or independent appraisals. If such assets are considered to be impaired, the
impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the assets.
Deferred Financing Costs
Costs incurred in securing long-term debt
are deferred and amortized, as a charge to interest expense, over the term of the related debt. In accordance with FASB ASU No.
2015-03, Interest – Imputation of Interest (Subtopic 835-30), Simplifying the Presentation of Debt Issuance Costs, the
Company presents debt issuance costs in the balance sheet as a direct deduction from the carrying amount of the debt liability, consistent
with debt discounts. In the case of long-term debt modifications, the Company follows the guidance provided by FASB ASC 470-50, Debt-Modification
and Extinguishments.
Convertible Notes Payable
Convertible notes payable, for which the embedded
conversion feature does not qualify for derivative treatment, are evaluated to determine if the effective or actual rate of conversion
per the terms of the convertible note agreement is below market value. In these instances, the Company accounts for the value
of the beneficial conversion feature (“BCF”) as a debt discount, which is then accreted to interest expense over the life
of the related debt using the straight-line method, which approximates the effective interest method.
Revenue Recognition
In accordance
with FASB ASC 606, Revenue from Contracts with Customers, the Company recognizes
revenue when it satisfies performance obligations, by transferring promised goods or services to customers, in an amount that reflects
the consideration to which the Company expects to be entitled in exchange for fullfilling those performance obligations.
Revenue for the years ended December 31, 2020
and 2019 was $0 and $34,485. Revenues for the year ended December 31, 2019 were derived from outsourcing engineers to a technology company.
The cost of payroll associated with the revenue for the years ended December 31, 2020 and 2019 was $0 and $27,488 and has been included
in product development costs.
Income Taxes
The Company follows FASB ASC 740 when accounting
for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred
income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets
and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the
periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary
to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for
the period plus or minus the change during the period in deferred tax assets and liabilities. Tax years from 2017 through 2020
remain subject to examination by major tax jurisdictions.
Stock-based Payments
The Company accounts for stock-based compensation
under the provisions of FASB ASC 718, Compensation—Stock Compensation, which requires the measurement and recognition
of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The
Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes model. The value of the portion of
the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. In
accordance with ASU No. 2018-07, Compensation – Stock Compensation (Topic 718), Improvements to Nonemployee Share-Based
Payment Accounting share-based payment transactions for acquiring goods and services from nonemployees
are included. Consistent with the accounting requirement for employee share-based payment awards, nonemployee share-based payment awards
within the scope of Topic 718 are measured at grant-date fair value of the equity instruments that an entity is obligated to issue when
the good has been delivered or the service has been rendered and any other conditions necessary to earn the right to benefit from the
instruments have been satisfied.
Advertising Costs
Advertising costs are expensed as incurred.
Advertising costs were $3,000 and $0 for the years ended December 31, 2020 and 2019. These costs when incurred are included in sales and
marketing expenses.
Product Development Costs
In accordance with FASB ASC 730, research
and development costs are expensed when incurred. Product and development costs were $1,138,164 and $237,658 for the years
ended December 31, 2020 and 2019.
Loss Per Share
The Company follows FASB ASC 260 when reporting
Earnings (Loss) Per Share resulting in the presentation of basic and diluted earnings (loss) per share. Because the Company
reported a net loss for each of the years ended December 31, 2020 and 2019, common stock equivalents, including preferred stock, stock
options and warrants were anti-dilutive; therefore, the amounts reported for basic and diluted loss per share were the same.
Segment Information
The Company is organized and operates as one
operating segment. In accordance with FASB ASC 280, Segment Reporting, the chief operating decision-maker has been identified
as the Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for
the entire Company subject to Board approval. Since the Company operates in one segment and provides one group of similar products, all
financial segment and product line information required by FASB ASC 280 can be found in the consolidated financial statements.
Recently Adopted Accounting Pronouncements
In
July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and
Derviatives and Hedging (Topic 815). The amendments
in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with
down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments,
a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own
stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked
financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result
of the existence of a down round feature. For freestanding equityclassified financial instruments, the amendments require entities that
present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered.
That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments
with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion
features (in Subtopic 470-20, Debt—Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments
in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending
content in the Codification, to a scope exception. Those amendments do not have an accounting effect. For public business entities, the
amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December
15, 2018. For all other entities, the amendments in Part I of this Update are effective for fiscal years beginning after December 15,
2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted for all entities, including
adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of
the beginning of the fiscal year that includes that interim period.
In November 2019, the FASB issued ASU No. 2019-08, Compensation
– Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606), Codification Improvements
– Share-Based Consideration Payable to a Customer. The amendments in this Update require that an entity measure and classify
share-based payment awards granted to a customer by applying the guidance in Topic 718. The amount recorded as a reduction of the transaction
price is required to be measured on the basis of the grant-date fair value of the share-based payment award in accordance with Topic 718.
The grant date is the date at which a grantor (supplier) and a grantee (customer) reach a mutual understanding of the key terms and conditions
of a share-based payment award. For entities that have not yet adopted the amendments in Update 2018-07, the amendments in this Update
are effective for (1) public business entities in fiscal years beginning after December 15, 2019, and interim periods within those fiscal
years, and (2) other than public business entities in fiscal years beginning after December 15, 2019, and interim periods within fiscal
years beginning after December 15, 2020. For entities that have adopted the amendments in Update 2018-07, the amendments in this Update
are effective in fiscal years beginning after December 15, 2019, and interim periods within those fiscal years.
Recently Issued Accounting Pronouncements
Not Yet Adopted
In December 2019, the FASB issued ASU No. 2019-12, Income
Taxes (Topic 740), Simplifying the Accounting for Income Taxes. The amendments in this Update simplify the accounting for income taxes
by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify
GAAP for other areas of Topic 740 by clarifying and amending existing guidance. For public business entities, the amendments in this Update
are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. For all other entities,
the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after
December 15, 2022. The Company is analyzing the pronouncement, but does not believe there will be any material impact on the financial
statements at this time.
In August 2020, the FASB issued ASU No. 2020-06, Debt
– Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own
Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The amendments
in this Update affect entities that issue convertible instruments and/or contracts in an entity’s own equity. For convertible instruments,
the instruments primarily affected are those issued with beneficial conversion features or cash conversion features because the accounting
models for those specific features are removed. However, all entities that issue convertible instruments are affected by the amendments
to the disclosure requirements in this Update. For contracts in an entity’s own equity, the contracts primarily affected are freestanding
instruments and embedded features that are accounted for as derivatives under the current guidance because of failure to meet the settlement
conditions of the derivatives scope exception related to certain requirements of the settlement assessment. FASB simplified the settlement
assessment by removing the requirements (1) to consider whether the contract would be settled in registered shares, (2) to consider whether
collateral is required to be posted, and (3) to assess shareholder rights. Those amendments also affect the assessment of whether an
embedded conversion feature in a convertible instrument qualifies for the derivatives scope exception. Additionally, the amendments in
this Update affect the diluted EPS calculation for instruments that may be settled in cash or shares and for convertible instruments.
The amendments in this Update are effective for public business entities that meet the definition of a Securities and Exchange Commission
(SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December
15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years
beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than
fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The FASB specified that an entity
should adopt the guidance as of the beginning of its annual fiscal year. The FASB decided to allow entities to adopt the guidance through
either a modified retrospective method of transition or a fully retrospective method of transition. The Company will adopt this pronouncement
on January 1, 2021 and as a result there will be a $10,987,578 reclassification between debt and equity.
NOTE 2 – GOING CONCERN
The accompanying consolidated financial statements
have been prepared assuming that the Company will continue as a going concern. The Company has incurred significant losses
and experienced negative cash flow from operations since inception. These conditions raise substantial doubt about the Company’s
ability to continue as a going concern. The financial statements do not include any adjustments that might result from the
outcome of this uncertainty.
Since inception, the Company has focused on
developing and implementing its business plan. The Company believes that its existing cash resources will not be sufficient
to sustain operations during the next twelve months. The Company currently needs to generate revenue in order to sustain
its operations. In the event that the Company cannot generate sufficient revenue to sustain its operations, the Company will
need to reduce expenses or obtain financing through the sale of debt and/or equity securities. The issuance of additional equity
would result in dilution to existing shareholders. If the Company is unable to obtain additional funds when they are needed
or if such funds cannot be obtained on terms acceptable to the Company, the Company would be unable to execute upon the business plan
or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results
of operations.
The Company’s current monetization model
is to derive revenues from levels of service fees, transaction fees and in some cases revenue sharing with banking and distribution partners.
As these bases of revenues grow, the Company expects to generate additional revenue to support operations.
In March
2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a pandemic which continues to spread throughout
the United States. On March 19, 2020, the Governor of Pennsylvania declared a health emergency and issued an order to close all nonessential
businesses until further notice. While these restrictions have been lifted, the Company has temporarily curtailed its business operations
and allows employees to work from home. While the Company expects this matter to negatively impact its results of operations, cash flow
and financial position, the related financial impact cannot be reasonably estimated at this time.
As of March 31, 2021, the Company has a cash
position of approximately $1,879,000. Based upon the current cash position and the Company’s planned expense run rate, management
believes the Company has funds currently to finance its operations through August 2021.
NOTE 3 - PATENTS AND TRADEMARKS
Costs associated with the registration of
patents have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents (20 years). Trademarks
are also being amortized on a straight-line basis over an estimated useful life of 20 years. At December 31, 2020 and 2019, capitalized
patent and trademark costs, net of accumulated amortization, were $328,486 and $354,624. Amortization expense for patents and
trademarks was $29,368 and $29,318 for the years ended December 31, 2020 and 2019.
NOTE 4 – INVESTMENT
In April 2018, Crowd Cart, Inc. issued 500,000
shares of its stock to the Company, representing a 5% ownership interest in Crowd Cart, Inc. and the Company issued 500,000 shares of
its common stock to Crowd Cart, Inc., at a fair value of $115,000, pursuant to a Stock Issuance and Stock Option Agreement. Crowd
Cart, Inc. had the option to receive an additional 500,000 shares of the Company’s common stock upon either:
|
1.
|
The formation of Zoom Mining Solutions, Inc. and the closing on a minimum 200 bitcoin mining machines being acquired into Zoom Mining Solutions, Inc. or
|
|
2.
|
The contribution of $500,000 in equity capital into Zoom Payment Solutions by investors introduced by Crowd Cart.
|
The option expired unexercised July 30, 2018.
In accordance with FASB ASC 320, Investments
– Other, the Company has determined that the investment is impaired other than temporarily and has recognized an impairment
loss during the year ended December 31, 2019, in the amount of $115,000.
NOTE 5 – ACCOUNTS PAYABLE AND ACCRUED
EXPENSES – RELATED PARTIES
As of December 31, 2020 and December 31, 2019,
the Company owed the Chief Executive Officer, who is also a more than 5% beneficial owner, a total of $184,507 and $158,220, consisting
of $78,462 and $0 in unpaid salary and consulting fees to a company owned by the Chief Executive Officer of $106,045 and $158,220.
Additionally as of December 31, 2020 and December
31, 2019, the Company owed the son of a more than 5% beneficial owner, Chief Executive Officer, President and Board member, $21,549 and
$32,000, pursuant to a consulting agreement.
As of December 31, 2020 and December 31, 2019,
the Company owed the Chief Financial Officer $83,648 and $118,596 in unpaid salary.
NOTE 6 – PAYCHECK PROTECTION PROGRAM LOAN PAYABLE
During April 2020, the Company
received $2,000 from the Emergency Injury Disaster Loan program and $79,500 from the Paycheck Protection Program. The Company has spent
all of the proceeds under these programs for payroll related expenses.
In accordance
with FASB ASC 470, Debt, the Company has recorded the loans as a current liability in the amount of $81,500. The Company will
record derecognition of the liability in accordance with FASB ASC 405-20, Liabilities-Extinguishment of Liabilities, when
either (1) the loan is, in part or wholly, forgiven and the Company has been legally released or (2) the Company pays off the loan.
NOTE 7 – LOANS PAYABLE
During
the years ended December 31, 2020 and 2019, the Company did not receive any loans with no formal repayment terms and 10% interest.
The Company also did not receive any loans with no formal repayment terms and no interest, during the years ended December 31, 2020 and
2019. The Company repaid $0 and $4,000 of these loans during the years ended December 31,
2020 and 2019. The Company also exchanged $43,000 and $0 of these loans payable for 10% Secured Convertible Promissory Notes, during
the years ended December 31, 2020 and 2019 (Note 9).
The
balance of the loans payable as of December 31, 2020 and December 31, 2019 was $42,600 and $85,600. Interest accrued on the loans was
$2,790 and $15,118 as of December 31, 2020 and December 31, 2019. Interest expense related to these loans payable was $4,153
and 5,865 for the years ended December 31, 2020 and 2019.
NOTE 8 – DEFERRED REVENUE
The Company received $200,000 in May 2018
as a down payment to develop software for the automotive industry. This will be a business to business and a business to consumer application
intended to remove friction in the industry and provide an improved and trusted consumer experience.
NOTE 9 – 10% SECURED CONVERTIBLE
NOTES PAYABLE - STOCKHOLDERS
On March 6, 2015, the Company, pursuant to
a Securities Purchase Agreement (the “Purchase Agreement”), issued $2,000,000 aggregate principal amount of its 10% Secured
Convertible Promissory Notes due March 5, 2016 (the “Notes”) to certain stockholders. On May 11, 2015, the Company
issued an additional $940,000 of Notes to stockholders. The maturity dates of the Notes have been extended most recently from
September 6, 2020 to October 31, 2021, with the consent of the Note holders.
The Notes are convertible by the holders,
at any time, into shares of the Company’s Series B Preferred Stock at a conversion price of $90.00 per share, subject to adjustment
for stock splits, stock dividends and similar transactions with respect to the Series B Preferred Stock only. Each share of
Series B Preferred Stock is currently convertible into 100 shares of the Company’s common stock at a current conversion price of
$0.90 per share, subject to anti-dilution adjustment as described in the Certificate of Designation of the Series B Preferred Stock. In
addition, pursuant to the terms of a Security Agreement entered into on May 11, 2015 by and among the Company, the Investors and a collateral
agent acting on behalf of the Investors (the “Security Agreement”), the Notes are secured by a lien against substantially
all of the Company’s business assets. Pursuant to the Purchase Agreement, the Company also granted piggyback registration
rights to the holders of the Series B Preferred Stock upon a conversion of the Notes.
During the years ended December 31, 2020 and
2019, $0 and $350,000 of the 10% Secured Convertible Promissory Notes were exchanged for $0 and $350,000 of the 4.0% Secured Convertible
Promissory Notes (Note 11).
The Company exchanged $43,000 and $0 of loans
payable and accrued interest thereon of $16,950 and $0 for $59,950 and $0 of the 10% Secured Convertible Promissory Notes (Note 7) during
the years ended December 31, 2020 and 2019.
The Company also exchanged, during the year
ended December 31, 2020, 2,223,929 common shares of ZS with an original capital contribution of $243,250 for $243,250 of the 10% Secured
Convertible Promissory Notes (Note 17).
The Notes are recorded as a current liability,
in the amount of $3,116,357 and $2,813,157 as of December 31, 2020 and 2019. Interest accrued on the notes was $1,855,368 and $1,567,582
as of December 31, 2020 and 2019. Interest expense related to these notes payable was $287,786 and $283,922 for the years ended
December 31, 2020 and 2019.
NOTE 10 – NOTES PAYABLE - STOCKHOLDERS
On December
14, 2017, the Company issued a promissory note in the amount of $100,000 non-interest bearing and maturing on December 21, 2017, along
with warrants to purchase 160,000 shares of the Company’s common stock, with an exercise price of $0.90, expiring in two years. In
accordance with FASB ASC 470-20, Debt with Conversion and Other Options, the proceeds of notes payable with detachable stock
purchase warrants have been allocated between the two based on the relative fair values of the debt instrument without the warrants and
of the warrants themselves at the time of issuance. The portion allocated to the warrants has been accounted for as a discount to the
notes payable and amortized over the term of the notes. The warrant values were treated as a discount to the value of the note
payable in accordance with FASB ASC 835-30-25, Recognition, and were accreted over the term of the note payable for financial
statement purposes. During the three months ended March 31, 2019, the promissory note holder received additional warrants
to purchase 175,000 shares of the Company’s common stock with an exercise price of $0.90, expiring in two years. The warrants
were valued at $21,305, fair value, using the Black-Scholes option pricing model to calculate the grant-date fair value of the options,
with the following assumptions: no dividend yield, expected volatility of 183.3% to 236.2%, risk free interest rate of 1.9% to 2.6% and
expected option term of 2 years. The warrant value of $21,305 was expensed during the year ended December 31, 2019. The Company
has not been able to raise sufficient funds to enable repayment of this promissory note.
On February 15, 2019, the Company reached an agreement
with the promissory note holder whereby the warrants would no longer be issued on a weekly basis and that the accrued interest of 10%
in addition to the warrants would be waived retrospectively in full. The reversal was recorded as a reduction in interest expense.
On June 17, 2019, the Company issued a 90 day
promissory note in the amount of $200,000, bearing interest at 10% along with options to purchase 100,000 shares of the Company’s
common stock at an exercise price of $0.90 for a term of 2 years, vesting immediately. Additionally, the note holder will receive up to
$200,000 from a 50/50 revenue split relative to a Norway joint venture. The options were valued at $9,075, fair value, using the Black-Scholes
option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected
volatility of 176.1%, risk free interest rate of 1.86% and expected option life of 2 years. The relative fair value of the
option was $8,757 and was recorded as a discount to the note payable in accordance with FASB ASC 835-30-25, Recognition, and
is being accreted over the term of the note payable for financial statement purposes. The Company has been unable to raise sufficient
funds to enable repayment of this promissory note.
On June 17, 2019, the Company issued a 90 day
promissory note in the amount of $50,000, bearing interest at 10% along with options to purchase 100,000 shares of the Company’s
common stock at an exercise price of $0.90 for a term of 2 years, vesting immediately. Additionally, the note holder will receive up to
$50,000 from a 50/50 revenue split relative to a Norway joint venture. The options were valued at $9,075, fair value, using the Black-Scholes
option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected
volatility of 176.1%, risk free interest rate of 1.86% and expected option life of 2 years. The relative fair value of the
option was $7,681 and was recorded as a discount to the note payable in accordance with FASB ASC 835-30-25, Recognition, and
is being accreted over the term of the note payable for financial statement purposes. The Company has been unable to raise sufficient
funds to enable repayment of this promissory note.
On July 19, 2019, the Company issued a 60 day
promissory note in the amount of $100,000, bearing interest at 10% along with options to purchase 100,000 shares of the Company’s
common stock at an exercise price of $0.90 for a term of 2 years, vesting immediately. Additionally, the note holder will receive up to
$40,000 from a 50/50 revenue split relative to a Norway joint venture. The options were valued at $8,312, fair value, using the Black-Scholes
option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected
volatility of 170.8%, risk free interest rate of 1.80% and expected option life of 2 years. The relative fair value of the
option was $7,674 and was recorded as a discount to the note payable in accordance with FASB ASC 835-30-25, Recognition, and
is being accreted over the term of the note payable for financial statement purposes. The Company has been unable to raise sufficient
funds to enable repayment of this promissory note.
On November 4, 2019, the Company issued a 90 day
promissory note in the amount of $225,000, bearing interest at 20% along with options to purchase 750,000 shares of the Company’s
common stock at an exercise price of $0.90 for a term of 2 years, vesting immediately. In addition to the interest, the note holder will
receive a total of $250,000 as principal repayment upon maturity of the promissory note. The additional $25,000 principal payment is considered
additional interest and is being amortized over the term of the loan. The options were valued at $68,452 fair value, using the Black-Scholes
option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected
volatility of 153.6%, risk free interest rate of 1.60% and expected option life of 2 years. The relative fair value of the
option was $53,738 and was recorded as a discount to the note payable in accordance with FASB ASC 835-30-25, Recognition, and
is being accreted over the term of the note payable for financial statement purposes. The Company has been unable to raise sufficient
funds to enable repayment of this promissory note.
On December 15, 2019, the Company issued a 60
day convertible debenture in the amount of $500,000, bearing interest at 10% along with options to purchase 350,000 shares of the Company’s
common stock at an exercise price of $0.90 for a term of 2 years, vesting immediately. In addition to the interest, the note holder will
receive a total of $550,000 as principal repayment and interest upon maturity of the promissory note. The additional $50,000 is considered
additional interest and is being amortized over the term of the loan. The options were valued at $28,243 fair value, using the Black-Scholes
option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected
volatility of 149.3%, risk free interest rate of 1.61% and expected option life of 2 years. The relative fair value of the
option was $26,864 and was recorded as a discount to the note payable in accordance with FASB ASC 835-30-25, Recognition, and
is being accreted over the term of the note payable for financial statement purposes. The Company has been unable to raise
sufficient funds to enable repayment of this promissory note. The debenture also has the following additional provisions:
|
1.
|
Holder’s Option to Increase Financing. The Company grants the Holder an option to purchase up to $10,000,000 in additional debentures which grant the Holder the right to convert such debentures into special cashless warrants that pay, upon a Deemed Liquidation Event, an amount per share equal to 600% of the exercise price, which is $0.90, of the warrants. Such option will expire 24 months after this Debenture has been paid or converted.
|
|
2.
|
As additional consideration for this Debenture, the Company agrees to share with the Holder fifty percent (50%) of the Company’s revenue received from the Norwegian joint-venture (“Joint-Venture Consideration”) until such Joint-Venture Consideration equals $500,000 in aggregate. Holder may, at Holder’s option, convert such Joint-Venture Consideration into the Series C Preferred Stock provided the Series C Preferred Stock terms have not expired.
|
|
3.
|
As additional consideration for this Debenture, the Company agrees to grant the Holder a right to purchase for $3,000,000 fifteen percent (15%) interest in the revenues of the Scandinavian joint-venture, or related entity (the “Scandinavian Option”). The Scandinavian Option shall expire 3 years from the Original Issue Date of this Debenture.
|
During the year ended December 31, 2020, the Company
issued $15,000 aggregate principal amount of its notes payable - stockholders with no formal repayment terms and 10% interest. These notes
in the principal amount of $15,000 were issued along with an option to purchase 25,000 shares of the Company’s common stock with
an exercise price of $0.90 and a term of 3 years, with a fair value of $4,470. The notes were repaid by June 30, 2020 and the fair value
of the options was expensed to interest expense.
Additionally, during the year ended December 31,
2020, the Company exchanged $107,000 of its notes payable – stockholders for $107,000 of the Company’s 4.0% Secured Convertible
Promissory Notes (Note 11).
The notes payable are recorded as a current
liability as of December 31, 2020 and 2019 in the amount of $1,095,000 and $1,161,969. Interest accrued on the notes as of
December 31, 2020 and 2019 was $115,917 and $29,481. Interest expense, including accretion of discounts, and warrants issues
related to these notes payable was $86,436 and $93,079 for the years ended December 31, 2020 and 2019.
NOTE 11 – 4.0% SECURED CONVERTIBLE
PROMISSORY NOTES PAYABLE – STOCKHOLDERS
On August 26, 2016, the Company, pursuant to a
Securities Purchase Agreement, issued $600,000 aggregate principal amount of its 4.0% Secured Convertible Promissory Notes due June 30,
2019 (the “New Secured Notes”) to certain accredited investors (“investors”). The Company issued additional
New Secured Notes during 2016, 2017, 2018, 2019 and 2020.
The New Secured Notes are convertible by the holders,
at any time, into shares of the Company’s authorized Series C Cumulative Convertible Preferred Stock (“Series C Preferred
Stock”) at a conversion price of $90.00 per share, subject to adjustment for stock splits, stock dividends and similar transactions
with respect to the Series C Preferred Stock only. Each share of Series C Preferred Stock is currently convertible into 100 shares
of the Company’s common stock at a current conversion price of $0.90 per share, subject to full ratchet anti-dilution adjustment
for one year and weighted average anti-dilution adjustment thereafter, as described in the Certificate of Designation of the Series C
Preferred Stock. Upon a liquidation event, the Company shall first pay to the holders of the Series C Preferred Stock,
on a pari passu basis with the holders of the Company’s outstanding Series A Preferred Stock and Series B Preferred Stock, an amount
per share equal to 700% of the conversion price (i.e., $630.00 per share of Series C Preferred Stock), plus all accrued and unpaid dividends
on each share of Series C Preferred Stock (the “Series C Preference Amount”). The Series C Preference Amount shall be
paid prior and in preference to payment of any amounts to the Common Stock. After the payment of all preferential amounts required
to be paid to the holders of shares of Series C Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and any additional
senior preferred stock, the Series C Preferred Stock participates in further distributions subject to an aggregate cap of seven and one-half
times (7.5x) the original issue price thereof, plus all accrued and unpaid dividends.
The maturity dates of the New Secured Notes were
extended by the investors to October 31, 2021.
During the year ended December 31, 2019, the
Company issued $945,000 aggregate principal amount of its New Secured Notes to certain accredited investors. The aggregate consideration
consisted of $595,000 cash and the exchange of $350,000 outstanding principal amount of 10% Secured Convertible Notes (Note 9).
During the year ended December 31, 2020, the
Company issued $2,062,000 aggregate principal amount of its New Secured Notes to certain investors, of which $107,000 was an exchange
of a note from a stockholder (Note 10).
The New Secured Notes are recorded as a current
liability in the amount of $9,494,250 and $7,432,250 as of December 31, 2020 and 2019. Interest accrued on the New Secured
Notes was $1,019,180 and $687,204 as of December 31, 2020 and 2019. Interest expense, including accretion of discounts related
to these notes payable was $331,619 and $292,237 for the years ended December 31, 2020 and 2019.
NOTE 12 - INCOME TAXES
The Company follows FASB ASC 740-10-10 whereby
an entity recognizes deferred tax assets and liabilities for future tax consequences or events that have been previously recognized in
the Company’s financial statements or tax returns. The measurement of deferred tax assets and liabilities is based on
provisions of enacted tax law. The effects of future changes in tax laws or rates are not anticipated.
At December 31, 2020, the Company has a net
operating loss (“NOL”) that approximates $76 million. Consequently, the Company may have NOL carryforwards available
for federal income tax purposes, which would begin to expire in 2028. Deferred tax assets would arise from the recognition
of anticipated utilization of these net operating losses to offset future taxable income.
The income tax (benefit) provision consists
of the following:
|
|
December 31,
|
|
|
|
2020
|
|
|
2019
|
|
Current
|
|
$
|
-
|
|
|
$
|
-
|
|
Deferred
|
|
|
(2,264,000
|
)
|
|
|
(889,000
|
)
|
Change in valuation allowance
|
|
|
2,264,000
|
|
|
|
889,000
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
-
|
|
|
$
|
-
|
|
The reconciliation of the statutory federal
rate to the Company’s effective income tax rate is as follows:
|
|
December 31, 2020
|
|
|
December 31, 2019
|
|
|
|
Amount
|
|
|
%
|
|
|
Amount
|
|
|
%
|
|
U.S federal income tax benefit at
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal statutory rate
|
|
$
|
(3,060,000
|
)
|
|
|
(21
|
)
|
|
$
|
(670,000
|
)
|
|
|
(21
|
)
|
State tax, net of federal tax effect
|
|
|
(1,692,000
|
)
|
|
|
(12
|
)
|
|
|
(223,000
|
)
|
|
|
(7
|
)
|
Non-deductible beneficial conversion feature expense
|
|
|
2,009,000
|
|
|
|
14
|
|
|
|
-
|
|
|
|
-
|
|
Non-deductible other expense
|
|
|
-
|
|
|
|
-
|
|
|
|
4,000
|
|
|
|
-
|
|
Change in valuation allowance
|
|
|
2,743,000
|
|
|
|
19
|
|
|
|
889,000
|
|
|
|
28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
|
|
$
|
-
|
|
|
|
-
|
|
|
$
|
-
|
|
|
|
-
|
|
The primary components of the Company’s
December 31, 2020 and 2019 deferred tax assets and related valuation allowances are as follows:
|
|
December 31,
|
|
|
|
2020
|
|
|
2019
|
|
|
|
|
|
|
|
|
Deferred tax asset for NOL carryforwards
|
|
$
|
(21,840,000
|
)
|
|
$
|
(20,418,000
|
)
|
Deferred tax asset for stock based compensation
|
|
|
(2,880,000
|
)
|
|
|
(1,559,000
|
)
|
Valuation allowance
|
|
|
24,720,000
|
|
|
|
21,977,000
|
|
|
|
|
|
|
|
|
|
|
Net
|
|
$
|
-
|
|
|
$
|
-
|
|
In assessing the realization of deferred tax
assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized.
The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which
the net operating losses and temporary differences become deductible. Management considered projected future taxable income and
tax planning strategies in making this assessment. The value of the deferred tax assets was offset by a valuation allowance, due
to the current uncertainty of the future realization of the deferred tax assets.
The timing and mannner in which the Company
can utilize operating loss carryforwards in any year may be limited by provisions of the Internal Revenue Code regarding changes in ownership
of corporations. Such limitation may have an impact on the ultimate realization of its carryforwards and future tax deductions.
The Company follows FASB ASC 740.10, which
provides guidance for the recognition and measurement of certain tax positions in an enterprise’s financial statements. Recognition
involves a determination of whether it is more likely than not that a tax position will be sustained upon examination with the presumption
that the tax position will be examined by the appropriate taxing authority having full knowledge of all relevant information.
The Company’s policy is to record interest
and penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations. As of January 1, 2020,
the Company had no unrecognized tax benefits and no charge during 2020, and accordingly, the Company did not recognize any interest or
penalties during 2020 related to unrecognized tax benefits. There is no accrual for uncertain tax positions as of December 31, 2020.
The Company files U.S. income tax returns
and a state income tax return. With few exceptions, the U.S. and state income tax returns filed for the tax years ending on December 31,
2017 and thereafter are subject to examination by the relevant taxing authorities.
NOTE 13 – CONVERTIBLE PREFERRED STOCK
REGO Payment Architectures, Inc. Series
A Preferred Stock
The
Series A Preferred Stock has a preference in liquidation equal to two times the Original Issue Price, or $21,570,000, to be paid out of
assets available for distribution prior to holders of common stock and thereafter participates with the holders of common stock in any
remaining proceeds subject to an aggregate cap of 2.5 times the Original Issue Price. The Series A Preferred Stockholders may cast the
number of votes equal to the number of whole shares of common stock into which the shares of Series A Preferred Stock can be converted. The
Series A Preferred Stock also contains customary approval rights with respect to certain matters. The Series A Preferred Stock
accrues dividends at the rate of 8% per annum.
The conversion feature of the Series A Preferred
Stock issued in January 2014 is an embedded derivative, which is classified as a liability in accordance with FASB ASC 815 and was valued
in accordance with FASB ASC 470 as a beneficial conversion feature at a fair market value of $1,648,825 at January 27, 2014, and $3,481,050
at December 31, 2020. This was classified as an embedded derivative liability and a discount to Series A Preferred Stock. Since
the Series A Preferred Stock can be converted at any time, the full amount of the discount was accreted and reflected as a deemed distribution.
The conversion feature of the Series A Preferred
Stock issued in April 2014 is an embedded derivative, which is classified as a liability in accordance with FASB ASC 815 and was valued
in accordance with FASB ASC 470 as a beneficial conversion feature at a fair market value of $3,489,000 at April 30, 2014, and $5,349,800
at December 31, 2020. This was classified as an embedded derivative liability and a discount to Series A Preferred Stock. Since
the Series A Preferred Stock can be converted at any time, the full amount of the discount was accreted and reflected as a deemed distribution.
The Warrants associated with the Series A
Preferred Stock were classified as equity, in accordance with FASB ASC 480-10-25. Therefore it is not necessary to bifurcate
these Warrants from the Series A Preferred Stock.
The conversion price of the Series A Preferred
Stock is currently $0.90 per share. The Series A Preferred Stock is subject to mandatory conversion if certain registration or related
requirements are satisfied and the average closing price of the Company’s common stock exceeds 2.5 times the conversion price over
a period of twenty consecutive trading days.
REGO Payment Architectures, Inc. Series
B Preferred Stock
The Series B Preferred Stock is pari passu
with the Series A Preferred Stock and has a preference in liquidation equal to two times the Original Issue Price, or $5,108,040, to be
paid out of assets available for distribution prior to holders of common stock and thereafter participates with the holders of common
stock in any remaining proceeds subject to an aggregate cap of 2.5 times the Original Issue Price. The Series B Preferred Stockholders
may cast the number of votes equal to the number of whole shares of common stock into which the shares of Series B Preferred Stock can
be converted. The Series B Preferred Stock also contains customary approval rights with respect to certain matters. The
Series B Preferred Stock accrues dividends at the rate of 8% per annum.
The conversion feature of the Series B Preferred
Stock is an embedded derivative, which is classified as a liability in accordance with FASB ASC 815 and was valued in accordance with
FASB ASC 470 as a beneficial conversion feature at a fair market value of $375,841 at October 30, 2014, and $2,156,728 at December 31,
2020. This was classified as an embedded derivative liability and a discount to Series B Preferred Stock. Since the Series
B Preferred Stock can be converted at any time, the full amount of the discount was accreted and reflected as a deemed distribution.
The Warrants associated with the Series B
Preferred Stock were classified as equity, in accordance with FASB ASC 480-10-25. Therefore it is not necessary to bifurcate
these Warrants from the Series B Preferred Stock.
The conversion price of the Series B Preferred
Stock is currently $0.90 per share. The Series B Preferred Stock is subject to mandatory conversion if certain registration or related
requirements are satisfied and the average closing price of the Company’s common stock exceeds 2.5 times the conversion price over
a period of twenty consecutive trading days.
REGO Payment Architectures, Inc. Series
C Preferred Stock
In August 2016, REGO authorized 150,000 shares
of the REGO’s Series C Cumulative Convertible Preferred Stock (“Series C Preferred Stock”). As of December 31,
2020, none of the Series C Preferred Stock shares were issued or outstanding. After the date of issuance of Series C Preferred Stock,
dividends at the rate of $7.20 per share will begin accruing and will be cumulative. The Series C Preferred Stock is pari passu with the
Series A Preferred Stock and Series B Preferred Stock and has a preference in liquidation equal to seven times its original issue price
to be paid out of assets available for distribution prior to holders of common stock and thereafter participates with the holders of common
stock in any remaining proceeds subject to an aggregate cap of 7.5 times its original issue price. The Series C Preferred Stockholders
may cast the number of votes equal to the number of whole shares of common stock into which the shares of Series C Preferred Stock can
be converted. The Series C Preferred Stock also contains customary approval rights with respect to certain matters.
As of December 31, 2020, the value of the
cumulative 8% dividends for all REGO preferred stock was $7,151,910. Such dividends will be paid when and if declared payable by the Company’s
board of directors or upon the occurrence of certain liquidation events. In accordance with FASB ASC 260-10-45-11, the Company
has recorded these accrued dividends as a current liability.
ZS Series A Preferred Stock
In November 2018, ZS pursuant to a Securities
Purchase Agreement (the “ZS Series A Purchase Agreement”), issued in a private placement to an accredited investor, 83,334
units at an original issue price of $3 per unit (the “ZS Original Series A Issue Price”), which includes one share of ZS’
Series A Cumulative Convertible Preferred Stock (the “ZS Series A Preferred Stock”) and one warrant to purchase one share
of ZS’ common stock with an exercise price of $3.00 per share expiring in three years (the “Series A Warrants”). ZS
raised $250,000 with respect to this transaction. Dividends on the ZS Series A Preferred Stock accrue at a rate of 8% per annum and are
cumulative. The ZS Series A Preferred Stock has a preference in liquidation equal to two times the ZS Original Series A Issue
Price to be paid out of assets available for distribution prior to holders of ZS common stock and thereafter participates with the holders
of ZS common stock in any remaining proceeds subject to an aggregate cap of 2.5 times the ZS Original Series A Issue Price. The ZS Series
A Preferred Stockholders may cast the number of votes equal to the number of whole shares of ZS common stock into which the shares of
ZS Series A Preferred Stock can be converted.
The conversion feature of the ZS Series A Preferred
Stock is an embedded derivative, which is classified as equity in accordance with FASB ASC 815 and was valued in accordance with FASB
ASC 470 as a beneficial conversion feature at a fair market value of $193,377 at the date of issuance. However in accordance with FASB
ASC 470, the value of the beneficial conversion feature is limited to the value of the ZS Series A Preferred Stock of $139,959 at the
date of issuance. This was classified as an embedded derivative and a discount to the ZS Series A Preferred Stock. Since the
ZS Series A Preferred Stock can be converted at any time, the full amount of the discount was accreted and reflected as a deemed distribution.
The warrants associated with the ZS Series A Preferred
Stock were also classified as equity, in accordance with FASB ASC 480-10-25. Therefore it is not necessary to bifurcate the
warrants from the ZS Series A Preferred Stock.
As of December 31, 2020,
the value of the cumulative 8% dividends for all ZS preferred stock was $43,333. Such dividends will be paid when and if declared payable
by the ZS’s board of directors or upon the occurrence of certain liquidation events. In accordance with FASB ASC 260-10-45-11,
the Company has recorded these accrued dividends as a current liability.
NOTE 14 – FAIR VALUE OF FINANCIAL INSTRUMENTS
Derivative Liabilities
For purposes of determining whether certain instruments
are derivatives for accounting treatment, the Company follows the accounting standard that provides guidance for determining whether an
equity-linked financial instrument, or embedded feature, is indexed to an entity’s own stock. The standard applies to any freestanding
financial instruments or embedded features that have the characteristics of a derivative, and to any freestanding financial instruments
that are potentially settled in an entity’s own common stock.
The Company has identified the following liabilities that are measured
at fair value on a recurring basis, summarized as follows:
December 31, 2020
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liability related to fair value of beneficial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
conversion feature
|
|
$
|
-
|
|
|
$
|
10,987,578
|
|
|
$
|
-
|
|
|
$
|
10,987,578
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
-
|
|
|
$
|
10,987,578
|
|
|
$
|
-
|
|
|
$
|
10,987,578
|
|
The following table details the approximate fair value measurements
within the fair value hierarchy of the Company’s derivative liabilities using Level 2 inputs:
|
|
Total
|
|
Balance at December 31, 2019
|
|
$
|
-
|
|
|
|
|
|
|
Change in fair value of derivative liability
|
|
|
10,987,578
|
|
|
|
|
|
|
Balance at December 31, 2020
|
|
$
|
10,987,578
|
|
As of December 31, 2020, the beneficial conversion feature of the Preferred
Stock is treated as an embedded derivative liability and changes in the fair value were recognized in earnings. The shares of Preferred
Stock are convertible into shares of the Company’s common stock, which did trade in an active securities market; therefore the embedded
derivative liability was valued using the following market based inputs:
Closing trading price of Rego common stock
|
|
$
|
1.38
|
|
|
|
|
|
|
Rego Series A Preferred Stock Effective Conversion Price issued January 27, 2014
|
|
|
0.69
|
|
|
|
|
|
|
Intrinsic value of conversion warrant per share
|
|
$
|
0.69
|
|
|
|
|
|
|
Closing trading price of Rego common stock
|
|
$
|
1.38
|
|
|
|
|
|
|
Rego Series B Preferred Stock Effective Conversion Price issued April 30, 2014
|
|
|
0.46
|
|
|
|
|
|
|
Intrinsic value of conversion warrant per share
|
|
$
|
0.92
|
|
|
|
|
|
|
Closing trading price of Rego common stock
|
|
$
|
1.38
|
|
|
|
|
|
|
Rego Series B Preferred Stock Effective Conversion Price issued October 31, 2014
|
|
|
0.62
|
|
|
|
|
|
|
Intrinsic value of conversion warrant per share
|
|
$
|
0.76
|
|
NOTE 15 –
STOCKHOLDERS’ EQUITY
Extension and Revaluation of Options
In April 2019, the Board of Directors of the
Company approved amendments extending the term of outstanding options to purchase in the aggregate 150,000 shares of common stock of the
Company at an exercise price $0.90 per share. These options were scheduled to expire in June 2019 and were each extended for
an additional two year period from the applicable current expiration date. The Company used the Black-Scholes option pricing model
to calculate the fair value at $21,975, with the following assumptions for the extended options: no dividend yield, expected volatility
of 179.2%, risk free interest rate of 2.3%, and expected option life of two years. The incremental increase in fair value of this term
extension was $21,964, which was expensed during the period.
On August 13, 2020, in conjunction with the execution
of the Chief Executive Officer’s employment agreement, the Company issued 250,000 shares of the Company’s common stock to
the Chief Executive Officer, which vested immediately. The fair value of the issuance of the common stock was $62,500, which was expensed
immediately.
On August 18, 2020, the Company issued to a member
of the Board of Directors, and to the Chief Financial Officer each 250,000 shares of the Company’s common stock, which vested immediately.
The aggregate fair value of the issuances of the common stock was $125,000, which was expensed immediately.
The Company entered into an financial
advisory agreement whereby generally the Company will pay the financial advisor a success fee equal to 6% of the capital committed in
a capital transaction.
The Company has also entered into a capital
advisory agreement whereby the Company will pay the capital advisor a structuring fee for placement by the Company of any securities including
equity, senior debt, mezzanine debt of other securities equal to 7% of the aggregate funds received. In addition, upon the closing of
a merger, sale of assets, consolidation or change of control of the Company, the Company shall pay a structuring fee equal to 1% of the
aggregate consideration. Both of these structuring fees are based on proceeds directly due to the efforts of the capital advisor.
NOTE 16 - STOCK OPTIONS AND WARRANTS
During 2008, the Board of Directors (“Board”)
of the Company adopted the 2008 Equity Incentive Plan (“2008 Plan”) that was approved by the shareholders. Under
the 2008 Plan, the Company was authorized to grant options to purchase up to 25,000,000 shares of common stock to any officer, other employee
or director of, or any consultant or other independent contractor who provides services to the Company. The Plan was intended
to permit stock options granted to employees under the 2008 Plan to qualify as incentive stock options under Section 422 of the Internal
Revenue Code of 1986, as amended (“Incentive Stock Options”). All options granted under the 2008 Plan, which are
not intended to qualify as Incentive Stock Options are deemed to be non-qualified options (“Non-Statutory Stock Options”). As
of December 31, 2020, options to purchase 1,900,000 shares of common stock have been issued and are unexercised, and no shares were available
for grants under the 2008 Plan.
During 2013, the Board adopted the 2013 Equity
Incentive Plan (“2013 Plan”), which was approved by stockholders at the 2013 annual meeting of stockholders. Under
the 2013 Plan, the Company is authorized to grant awards of stock options, restricted stock, restricted stock units and other stock-based
awards of up to an aggregate of 5,000,000 shares of common stock to any officer, employee, director or consultant. The 2013
Plan is intended to permit stock options granted to employees under the 2013 Plan to qualify as Incentive Stock Options. All
options granted under the 2013 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be Non-Statutory Stock
Options. As of December 31, 2020, under the 2013 Plan grants of restricted stock and options to purchase 4,917,500 shares of
common stock have been issued and 3,767,500 are unvested or unexercised, and 82,500 shares of common stock remained available for grants
under the 2013 Plan.
The 2008 Plan and 2013 Plan are administered
by the Board or its compensation committee, which determines the persons to whom awards will be granted, the number of awards to be granted,
and the specific terms of each grant, including the vesting thereof, subject to the terms of the applicable Plan.
In connection with Incentive Stock Options,
the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or
110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company).
Prior to January 1, 2014, volatility in all
instances presented is REGO’s estimate of volatility that is based on the volatility of other public companies that are in closely
related industries to REGO. Beginning January 1, 2014, volatility in all instances presented is REGO’s estimate of volatility
that is based on the historical volatility of the REGO’s stock.
The following table presents the weighted-average
assumptions used to estimate the fair values of the stock options granted by REGO during the years ended December 31, 2020 and 2019:
|
|
2020
|
|
|
2019
|
|
|
|
|
|
|
|
|
Risk Free Interest Rate
|
|
|
0.3
|
%
|
|
|
1.8
|
%
|
Expected Volatility
|
|
|
161.8
|
%
|
|
|
163.4
|
%
|
Expected Life (in years)
|
|
|
4.5
|
|
|
|
2.7
|
|
Dividend Yield
|
|
|
0
|
%
|
|
|
0
|
%
|
Weighted average estimated fair value of options
|
|
|
|
|
|
|
|
|
during the period
|
|
$
|
0.23
|
|
|
$
|
0.11
|
|
The following table summarizes the activities
for REGO stock options for the years ended December 31, 2020 and 2019:
During the years ended December 31, 2020 and
2019, the weighted average fair value of stock options granted during the year was $0.23 and $0.11. The fair value of stock
options for employees is expensed over the vesting term in accordance with the terms of the related stock option agreements and for consultants
is expensed over the vesting term, if that is shorter than the term of the consulting agreement, otherwise over the term of the consulting
agreement.
For the years ended December 31, 2020 and
2019, the Company expensed $841,885 and $536,896 relative to the fair value of stock options granted.
As of December 31, 2020, there was $0 of unrecognized compensation
cost related to outstanding stock options. The difference, if any, between the stock options exercisable at December 31, 2020 and
the stock options exercisable and expected to vest relates to management’s estimate of options expected to vest in the future.
The following table summarizes the activities
for REGO’s unvested options for the years ended December 31, 2020 and 2019:
The following table summarizes the activities
for the REGO’s warrants for the years ended December 31, 2020 and 2019:
During the year ended December 31, 2020, the
Company issued warrants to purchase 1,500,000 shares of common stock commensurate with a consulting agreement. The warrants were valued
at $184,048 fair value, using the Black-Scholes option pricing model to calculate the grant-date fair value of the warrants, with the
following assumptions: no dividend yield, expected volatility of 139.0% to 140.8%, risk free interest rate of 0.14% to 0.36% and expected
life of 2 years. The fair value of the warrants was $184,048 and was expensed immediately.
During the years ended December 31, 2020 and
2019, the weighted average fair value of warrants granted during the year was $0.12 and $0.09.
During the years ended December 31, 2020 and
2019, the Company expensed $184,048 and $343,196 relative to warrants.
The following table summarizes the activities
for ZS’s stock options for the years ended December 31, 2020 and 2019:
For the years ended December 31, 2020 and
2019, ZS expensed $0 and $28,051 relative to the fair value of stock options granted.
As of December 31, 2020, there was $0 of unrecognized
compensation cost related to outstanding ZS stock options.
The following table summarizes the activities
for ZS’s warrants for the years ended December 31, 2020 and 2019:
The following table summarizes the activities
for ZBS’s stock options for the years ended December 31, 2020 and 2019:
For the years ended December 31, 2020 and
2019, ZBS expensed $0 with respect to options.
The following table summarizes the activities
for ZCS’s stock options for the years ended December 31, 2020 and 2019:
For the years ended December 31, 2020 and
2019, ZCS expensed $0 with respect to options.
The following table summarizes the activities
for ZPS’s stock options for the years ended December 31, 2020 and 2019:
For the years ended December 31, 2020 and
2019, ZPS expensed $0 with respect to options.
During the year ended December 31, 2020, the
Company exchanged 2,223,929 common shares of ZS with an original capital contribution of $243,250 for $243,250 of the 10% Secured Convertible
Promissory Notes of REGO (Note 9).
Losses incurred by the noncontrolling interests
for the years ended December 31, 2020 and 2019 were $201 and $7,229.
For the years ended December 31, 2020
and 2019, total rent expense under leases amounted to $41,202 and $23,124. At December 31, 2020, the Company was not
obligated under any non-cancelable operating leases.
In August 2020, the Company entered into an
employment agreement with the Chief Executive Officer who is a more than 5% beneficial owner. The Company had also previously entered
into a consulting agreement with a Company owned by the Chief Executive Officer at a cost of $15,000 per month. The consulting agreement
was terminated upon the execution of the Chief Executive Officer’s employment agreement. As of December 31, 2020 and 2019, the Company
owed the Chief Executive Officer $78,461 and $0 relative to the employment agreement. As of December 31, 2020 and 2019, the Company owed
the consulting company $106,045 and $158,220 and expensed $112,500 and $180,000 to the consulting company. The amounts owed have
been included in accounts payable and accrued expenses – related parties.
The Company entered into an agreement in 2020
for the preparation of all of the corporate income taxes with a company owned by the Chief Financial Officer and expensed $10,000 for
the years ended December 31, 2020 and 2019, in accordance with the agreement.
The Company has entered into a consulting
agreement with the son of the Chief Executive Officer, at a cost of $5,000 per month, plus expenses. As of December 31, 2020 and
2019, the Company owed the consultant $21,549 and $32,000. For the years ended December 31, 2020 and 2019, the Company has expensed $60,000
to this consultant.
During the years ended December 31, 2020 and
2019, the Company received revenue of $0 and $34,485 from a technology company, with which the Company had a memorandum of understanding,
for the outsourcing of the Company’s engineers for development.